VSee Health (VSEE)
NASDAQ:VSEE
Want to see VSEE full AI Analyst Report?
VSEE Stock Chart & Stats
$0.38
-$0.02(-1.82%)
At close: 4:00 PM EST
$0.38
-$0.02(-1.82%)
Day’s Range― - ―
52-Week Range$0.11 - $2.52
Previous CloseN/A
Volume71.92K
Average Volume (3M)1.90M
Market Cap
$5.62M
Enterprise Value$2.78M
Total Cash (Recent Filing)$1.35M
Total Debt (Recent Filing)$2.14M
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Sep 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding48,600,000
10 Day Avg. Volume5,577,105
30 Day Avg. Volume1,899,699
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap0.50
Enterprise Value/Revenue0.19
Enterprise Value/Gross Profit0.42
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.24
Revenue Forecast (FY)$21.60M
Bulls Say, Bears Say
Bulls Say
HIPAA-compliant Telehealth PlatformVSee’s core product is a HIPAA-compliant telehealth and clinical workflow platform, a durable asset in healthcare. Enterprise-grade compliance and workflow integration support recurring contracts, stickier customer relationships, and predictable subscription and services revenue over multiple quarters.
Improved Leverage; Low Debt Relative To EquityLower debt-to-equity reduces interest burden and gives financial flexibility amid ongoing losses. Improved leverage versus 2025 means less near-term pressure from creditors, supporting the company’s ability to extend runway or invest in product and sales without large incremental secured borrowing.
Contingent $10M Standby Equity FacilityA committed standby equity agreement provides a sizable contingent capital source through 2029, improving long-term liquidity optionality. While dilutive, the facility structurally reduces immediate solvency risk and enables continued investment in platform adoption and implementation services.
Bears Say
Material Operating Cash BurnSustained negative operating cash flow of roughly -$5.5M TTM is a structural weakness: it requires continual external funding, limits ability to self-fund growth, increases dilution risk, and constrains long-term investments in R&D and sales needed to scale the platform.
Deep Operating And Net Losses; Volatile MarginsVery large operating and net losses with highly variable margins undermine profitability prospects. Persistent negative margins prevent reinvestment from earnings, reduce returns on capital, and create uncertainty around when the business can sustainably reach breakeven.
Reliance On Costly Short-term FinancingUse of high-cost short-term debt (18% interest) and terms tying repayment to equity draws signal weak access to inexpensive capital. Structurally raises financial burden, increases refinancing risk, and can force dilutive equity raises or asset sales over the medium term.
VSee Health News
VSEE FAQ
What was VSee Health’s price range in the past 12 months?
VSee Health lowest stock price was $0.11 and its highest was $2.52 in the past 12 months.
What is VSee Health’s market cap?
VSee Health’s market cap is $5.62M.
When is VSee Health’s upcoming earnings report date?
VSee Health’s upcoming earnings report date is Sep 28, 2026 which is in 100 days.
How were VSee Health’s earnings last quarter?
Currently, no data Available
Is VSee Health overvalued?
According to Wall Street analysts VSee Health’s price is currently Overvalued.
Does VSee Health pay dividends?
VSee Health does not currently pay dividends.
What is VSee Health’s EPS estimate?
VSee Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VSee Health have?
VSee Health has 48,600,000 shares outstanding.
What happened to VSee Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VSee Health?
Currently, no hedge funds are holding shares in VSEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VSee Health
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Technical Analysis
Ownership Overview
11.34% Insiders
0.58% Mutual Funds
7.47% Other Institutional Investors
80.17% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---